ER + breast cancer patient RNAseq data from TCGA revealed an association of ROS and PPAR signaling with NNAT expression and in silico analysis of the NNAT promotor revealed consensus binding sites for NRF1 and PPARα/PPARγ, as well as the cell cycle transcription factor, E2F4. Here, NNAT is linked to breast carcinoma.